NCT06322342 2025-12-26Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentReveal Pharmaceuticals Inc.Phase 2 Completed18 enrolled
NCT05684692 2025-10-30Screening Trial for Pain Relief in Schwannomatosis (STARFISH)Massachusetts General HospitalPhase 2 Recruiting40 enrolled